Clinical Profile of Thromboembolic Events in Patients With Hypertrophic Cardiomyopathy in a Regional Japanese Cohort ― Results From Kochi RYOMA Study ―
弘田 隆省
Circulation Journal 83 (8) 1747-1754 201908-
|
Reconsideration of the cut-off value of angiotensin-converting enzyme for screening of sarcoidosis in Japanise patients
弘田 隆省
Jounal of Cardiology 74 (2019) 507-511 201907-
|
Prevalence and clinical features of Fabry disease in Japanese male patients with diagnosis of hypertrophic cardiomyopathy
弘田 隆省
Journal of Cardiology 69 (1) 302-307 201701-
|
Prognostic Significance of Non-Dilated Left Ventricular Size and Mitral Regurgitation in Patients With Dilated Phase of Hypertrophic Cardiomyopathy
弘田 隆省
International Heart Journal 58 (1) 63-68 2017-
|
N‐terminal pro‐brain natriuretic peptide is a useful marker to identify latent heart failure patients in older adults in a rural outpatient clinic
弘田 隆省
Geriatrics Gerontol Int 17 1648-1653 2017-
|
Gender differences in the clinical features of hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations
弘田 隆省
Journal of Cardiology 65 (5) 423-428 201505-
|
Differentiation of infiltrative cardiomyopathy from hypertrophic cardiomyopathy using high-sensitivity cardiac troponin T: a case-control study
弘田 隆省
BMC Cardiovascular Disorders 15 (53)
|
Clinical Significance of High-Sensitivity Cardiac Troponin T in Patients With Dilated Cardiomyopathy
弘田 隆省
International Heart Journal 56 (3) 309-313 2015-
|
Significance of High-Sensitivity Cardiac Troponin T in Hypertrophic Cardiomyopathy
弘田 隆省
Journal of the American College of Cardiology 62 (14) 1252-1259 2013-
|
Rhythm Control Should Be Better for the Management of Patients With Atrial Fibrillation and Heart Failure
弘田 隆省
Circulation Journal 75 (4) 979-985 2011-
|
Genetic Screening and Double Mutation in Japanese Patients With Hypertrophic Cardiomyopathy
弘田 隆省
Circulation Journal 75 (11) 2654-2659 2011-
|
Combined Measurements of Cardiac Troponin I and Brain Natriuretic Peptide Are Useful for Predicting Adverse Outcomes in Hypertrophic Cardiomyopathy
弘田 隆省
Circulation Journal 75 (4) 919-926 2011-
|
Gender-specific differences in the clinical features of hypertrophic cardiomyopathy in a community-based Japanese population: Results from Kochi RYOMA study
弘田 隆省
Journal of Cardiology 56 (3) 314-319 201011-
|
A frameshift deletion mutation in the cardiac myosin-binding protein C gene associated with dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy
弘田 隆省
Journal of Cardiology 56 (2) 189-196 201009-
|
A novel cardiac myosin-binding protein C S297X mutation in hypertrophic cardiomyopathy
弘田 隆省
Journal of Cardiology 56 (1) 59-65 201002-
|
Clinical Features of the Dilated Phase of Hypertrophic Cardiomyopathy in Comparison With Those of Dilated Cardiomyopathy
弘田 隆省
Clinical Cardiology 33 (7) E24-E28 2010-
|
Serum Cardiac Troponin I is Related to Increased Left Ventricular Wall Thickness, Left Ventricular Dysfunction, and Male Gender in Hypertrophic Cardiomyopathy
弘田 隆省
Clinical Cardiology 33 (2) E1-E7 2010-
|
Utility of tissue Doppler imaging to predict exercise capacity in hypertrophic cardiomyopathy: Comparison with B-type natriuretic peptide
弘田 隆省
Journal of Cardiology 53 (3) 361-367 200906-
|
Clinical Profiles of Hypertrophic Cardiomyopathy With Apical Phenotype
弘田 隆省
Circulation Journal 73 (12) 2330-2336 2009-
|
Clinical impact of atrial fibrillation in patients with hypertrophic cardiomyopathy
弘田 隆省
Circulation Journal 73 (9) 1599-1605 2009-
|
Improvement in prognosis of dilated cardiomyopathy in the elderly over the past 20 years
弘田 隆省
Journal of Cardiology 52 (2) 111-117 200810-
|
Morphologic Characteristics of Hypertrophic Cardiomyopathy of the Elderly With Cardiac Myosin-Binding Protein C Gene Mutations
弘田 隆省
Circulation Journal 70 (7) 875-879 2006-
|
Patients’ Characteristics and Clinical Course of Hypertrophic Cardiomyopathy in a Regional Japanese Cohort ― Results From Kochi RYOMA Study ―
弘田 隆省
Circulation Journal 82 (3) 824-830 2018-
|
|
すべて表示
５件表示
|
